Navidea Biopharmaceuticals (NAVB) PT Raised to $3 at Maxim Group
Tweet Send to a Friend
Maxim Group analyst Jason McCarthy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
